Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...

Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment at Penn Medicine Radiation Oncology in Philadelphia. The diagnosis followed ...

WASHINGTON (AP) — Former President Joe Biden on Monday completed a round of radiation therapy treatment for the aggressive form of prostate cancer he was diagnosed with after leaving office, a ...

Find out how ADT + ARPI outperforms ADT alone in mHSPC, boosting survival and treatment persistence. Read more on real-world outcomes.

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

Former President Joe Biden has completed a round of radiation therapy for an aggressive form of prostate cancer. The 82-year-old finished several weeks of therapy at Penn Medicine Radiation Oncology ...